Skip to Content

Zafirlukast Pregnancy and Breastfeeding Warnings

Zafirlukast is also known as: Accolate

Zafirlukast Pregnancy Warnings

Zafirlukast has been assigned to pregnancy category B by the FDA. Maternal toxicity and deaths in rats were seen at 800 times the maximum recommended human daily dose on a mg/m2 basis. There are no controlled data in human pregnancy. Zafirlukast is only recommended for use during pregnancy when benefit outweighs risk.

See references

Zafirlukast Breastfeeding Warnings

Zafirlukast is excreted into human milk. The manufacturer recommends that due to the potential for serious reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Animal studies have shown potential for tumorigenicity in mouse and rat studies and increased sensitivity in neonatal rats and dogs to the adverse effects of zafirlukast.

See references

References for pregnancy information

  1. "Product Information. Accolate (zafirlukast)." Zeneca Pharmaceuticals, Wilmington, DE.

References for breastfeeding information

  1. "Product Information. Accolate (zafirlukast)." Zeneca Pharmaceuticals, Wilmington, DE.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.